类疫苗配方具有结构上不同的STING激动剂药基,可诱导离散的,有效的抗瘤反应
Kefan Song1, Dinh Chuong Nguyen2, Yonghui Wang1
1Department of Bioengineering, University of Washington, Seattle, WA 98195.
概括
新型病毒启发的聚合物 (VIPER) 与STING药物聚合物相结合,增强了癌症疫苗的免疫性. 这种方法改善了CD8+T细胞激活,并在临床前癌症模型中证明了有效性,为更强大的癌症免疫疗法铺平了道路.
科学领域:
- 免疫学 免疫学 免疫学
- 聚合物化学 聚合物化学
- 纳米技术 纳米技术
背景情况:
- 类癌症疫苗面临着低免疫性和T细胞激活的挑战.
- 现有的疫苗平台需要改进的输送和辅助策略.
- 干扰素基因刺激剂 (STING) 激动剂可以提高疫苗的效力,但具有毒性风险.
研究的目的:
- 开发新的STING药基,以向向树突细胞 (DCs) 提供向的药基.
- 将STING药基与病毒启发的内体释放聚合物 (VIPER) 平台结合起来.
- 评估这些组合平台在增强抗瘤免疫力的有效性.
主要方法:
- 开发了两种STING药结构:polySTING (性聚合物) 和NPSTING (纳米粒子双块聚合物).
- 使用可切割的甲素链接剂和DC向部分用于细胞内输送.
- 在B16-OVA黑色素瘤和MC38结肠癌模型中使用VIPER-STING药剂组合.
- 评估了免疫细胞激活,瘤透和治疗疗效,包括与抗PD-1疗法结合治疗.
主要成果:
- 与免费的STING激动剂相比,polySTING和NPSTING都增强了STING激活和DC成熟.
- NPSTING改善了对淋巴结的STING激动剂的输送,而polySTING改善了全身的输送.
- VIPER-NPSTING增加了淋巴结中的抗原呈现性DC和中的抗原反应性CD8+T细胞.
- VIPER-polySTING增加了瘤透的CD8+ T细胞和CD8+ DCs.
- 两种VIPER-STING药物组合在临床前癌症模型中都显示出有效性.
- 与抗PD-1的联合治疗导致一些小鼠的瘤缓解和免疫力.
结论:
- 结构上不同的STING药物,当与VIPER平台相结合时,会诱导强大而独特的抗瘤免疫反应.
- 通过药物制造商向DC提供SING激动剂的向输送克服了免费STING激动剂的局限性.
- 这种综合方法为开发下一代癌症疫苗提供了一个有希望的战略,其有效性得到了提高.
更多相关视频
08:10Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector
Published on: November 28, 2018
9.0K
11:58Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
Published on: March 8, 2018
8.0K
相关概念视频
Cancer Vaccines
945
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
945
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Antigens Involved in Adaptive Immunity
1.3K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
1.3K
